WallStSmart

PetMed Express Inc (PETS)vsWellgistics Health, Inc. Common Stock (WGRX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PetMed Express Inc generates 1176% more annual revenue ($179.02M vs $14.03M). WGRX leads profitability with a 0.0% profit margin vs -32.0%. PETS earns a higher WallStSmart Score of 43/100 (D).

PETS

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.3Quality: 5.0

WGRX

Avoid

30

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 2/9Altman Z: -14.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PETSUndervalued (+73.5%)

Margin of Safety

+73.5%

Fair Value

$11.21

Current Price

$1.82

$9.39 discount

UndervaluedFair: $11.21Overvalued

Intrinsic value data unavailable for WGRX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PETS2 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

EPS GrowthGrowth
266.7%10/10

Earnings expanding 266.7% YoY

WGRX1 strengths · Avg: 10.0/10
Debt/EquityHealth
-1.9110/10

Conservative balance sheet, low leverage

Areas to Watch

PETS4 concerns · Avg: 2.8/10
PEG RatioValuation
2.324/10

Expensive relative to growth rate

Market CapQuality
$36.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-100.6%2/10

ROE of -100.6% — below average capital efficiency

Revenue GrowthGrowth
-7.9%2/10

Revenue declined 7.9%

WGRX4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$9.35M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : PETS

The strongest argument for PETS centers on Price/Book, EPS Growth.

Bull Case : WGRX

The strongest argument for WGRX centers on Debt/Equity.

Bear Case : PETS

The primary concerns for PETS are PEG Ratio, Market Cap, Return on Equity.

Bear Case : WGRX

The primary concerns for WGRX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

PETS profiles as a turnaround stock while WGRX is a value play — different risk/reward profiles.

PETS is growing revenue faster at -7.9% — sustainability is the question.

PETS generates stronger free cash flow (-395,000), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

PETS scores higher overall (43/100 vs 30/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PetMed Express Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

PetMed Express, Inc., doing business as 1-800-PetMeds, is a pet pharmacy in the United States. The company is headquartered in Delray Beach, Florida.

Wellgistics Health, Inc. Common Stock

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Wellgistics Health, Inc. is a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company is headquartered in Tampa, Florida.

Want to dig deeper into these stocks?